Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 38% ± 17% | |
ciliated cell | 7 studies | 23% ± 8% | |
retinal rod cell | 7 studies | 36% ± 13% | |
CD4-positive, alpha-beta T cell | 6 studies | 19% ± 3% | |
retinal cone cell | 6 studies | 38% ± 18% | |
CD8-positive, alpha-beta T cell | 6 studies | 18% ± 1% | |
ionocyte | 5 studies | 21% ± 4% | |
retinal ganglion cell | 5 studies | 69% ± 19% | |
epithelial cell | 5 studies | 43% ± 12% | |
amacrine cell | 5 studies | 29% ± 12% | |
retina horizontal cell | 5 studies | 24% ± 10% | |
Mueller cell | 5 studies | 40% ± 20% | |
basal cell | 5 studies | 27% ± 7% | |
regulatory T cell | 5 studies | 18% ± 1% | |
endothelial cell | 4 studies | 37% ± 26% | |
abnormal cell | 4 studies | 37% ± 16% | |
glutamatergic neuron | 4 studies | 50% ± 21% | |
microglial cell | 3 studies | 29% ± 17% | |
extravillous trophoblast | 3 studies | 32% ± 2% | |
OFF-bipolar cell | 3 studies | 37% ± 15% | |
secretory cell | 3 studies | 19% ± 3% | |
muscle cell | 3 studies | 27% ± 9% | |
GABAergic neuron | 3 studies | 43% ± 17% | |
dendritic cell | 3 studies | 21% ± 3% | |
natural killer cell | 3 studies | 19% ± 3% | |
ependymal cell | 3 studies | 34% ± 13% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 30% ± 7% | |
plasmacytoid dendritic cell | 3 studies | 18% ± 2% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8061.48 | 1444 / 1445 | 99% | 57.99 | 182 / 183 |
thymus | 100% | 6090.78 | 652 / 653 | 98% | 56.87 | 593 / 605 |
brain | 98% | 8773.12 | 2577 / 2642 | 99% | 57.27 | 698 / 705 |
intestine | 100% | 5723.61 | 965 / 966 | 97% | 54.19 | 509 / 527 |
kidney | 99% | 6006.12 | 88 / 89 | 97% | 145.49 | 878 / 901 |
bladder | 100% | 9814.57 | 21 / 21 | 95% | 58.56 | 481 / 504 |
uterus | 100% | 6204.26 | 170 / 170 | 94% | 60.38 | 432 / 459 |
prostate | 99% | 6245.24 | 243 / 245 | 90% | 26.09 | 454 / 502 |
lung | 92% | 2803.95 | 534 / 578 | 96% | 58.95 | 1104 / 1155 |
skin | 100% | 6979.16 | 1807 / 1809 | 84% | 44.21 | 396 / 472 |
ovary | 76% | 2587.87 | 136 / 180 | 96% | 53.47 | 414 / 430 |
stomach | 73% | 2038.54 | 261 / 359 | 95% | 44.49 | 272 / 286 |
breast | 98% | 3372.26 | 452 / 459 | 64% | 23.54 | 715 / 1118 |
adrenal gland | 49% | 1365.28 | 127 / 258 | 77% | 54.71 | 176 / 230 |
pancreas | 18% | 367.12 | 60 / 328 | 97% | 61.08 | 173 / 178 |
blood vessel | 100% | 9024.31 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 4176.48 | 1178 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 52.13 | 44 / 45 |
spleen | 97% | 2359.54 | 233 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 61.91 | 28 / 29 |
heart | 95% | 8271.86 | 820 / 861 | 0% | 0 | 0 / 0 |
muscle | 73% | 4715.66 | 587 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 71% | 27.12 | 57 / 80 |
peripheral blood | 56% | 4573.02 | 516 / 929 | 0% | 0 | 0 / 0 |
liver | 8% | 226.23 | 19 / 226 | 18% | 9.80 | 73 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_0061621 | Biological process | canonical glycolysis |
GO_0030388 | Biological process | fructose 1,6-bisphosphate metabolic process |
GO_0005945 | Cellular component | 6-phosphofructokinase complex |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0048029 | Molecular function | monosaccharide binding |
GO_0003872 | Molecular function | 6-phosphofructokinase activity |
GO_0016208 | Molecular function | AMP binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0070095 | Molecular function | fructose-6-phosphate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PFKP |
Protein name | PFKP protein ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase) 6-phosphofructokinase type C (Phosphofructo-1-kinase isozyme C) Phosphofructokinase, platelet ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) |
Synonyms | PFKF |
Description | FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. . FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. . |
Accessions | Q01813 ENST00000678089.1 H0Y757 ENST00000678206.1 B1APP6 A0A7I2V3Z0 V9GY25 H0Y3Y3 ENST00000407806.2 Q49A78 ENST00000415005.6 ENST00000676796.1 ENST00000381125.9 [Q01813-1] ENST00000381075.7 ENST00000699222.1 ENST00000413079.1 A0A7I2V5S1 ENST00000607886.5 Q5VSR5 A0A7I2YQB6 ENST00000468050.1 ENST00000433193.2 A0A8V8TMY4 V9GYV7 |